JOHN OSTH — President and CEO of Celula, Inc.
John Osth, President and CEO of Celula, Inc., joined the company May 1, 2008.
Prior to joining Celula, Mr. Osth was COO of HematoLogics, Inc. in Seattle, WA. HematoLogics provides advanced diagnostics lab services to Pathologists and Oncologists. Testing service technologies included flow cytometry, cell sorting, Polymerase Chain Reaction (PCR), Fluorescence In-situ Hybridization (FISH) and cytogenetics. Mr. Osth was responsible for all business operations including financial, sales and marketing.
Prior to joining HematoLogics, Inc., Mr. Osth was founder, Chairman and CEO of QuantumCor, Inc., a company developing a percutaneous method for repairing mitral valves. In addition to his role at Celula, Mr. Osth remains Chairman of QuantumCor, Inc. Previous to QuantumCor, Mr. Osth was employed by Baxter Healthcare where he was President of the Immunotherpy Division and headed Baxter’s European Research and Development Group based in Belgium.
Mr. Osth received his MBA from The Executive Program at the University of Chicago in 1978. He also holds an MS in Engineering from the University of Illinois, Champaign, IL, and a BS in Engineering from the U.S. Naval Academy, Annapolis, MD.
